L. Moreno

发表

Risk factors associated with ampicillin resistance in patients with bacteraemia caused by Enterococcus faecium.

F. Baquero, P. Martín-Dávila, E. Loza, 2002, The Journal of antimicrobial chemotherapy.

The role of liver biopsy in the management of chronic hepatitis C in patients infected with the human immunodeficiency virus.

C. Quereda, E. Navas, S. Moreno, 2004, Human pathology.

Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients

C. Quereda, S. Moreno, M. Pérez-Elías, 2003, AIDS.

Partial Splenic Embolization for the Treatment of Hypersplenism in Cirrhotic HIV/HCV Patients Prior to Pegylated Interferon and Ribavirin

C. Quereda, S. Moreno, M. Pérez-Elías, 2004, Antiviral therapy.

Viral kinetics and early prediction of nonresponse to peg‐IFN‐α‐2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus *

C. Quereda, M. Pérez-Elías, A. Antela, 2006, Journal of viral hepatitis.

High Rate of Didanosine-Related Mitochondrial Toxicity in HIV/HCV-Coinfected Patients Receiving Ribavirin

A. Muriel, C. Quereda, E. Navas, 2004, Antiviral therapy.

Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.

C. Quereda, S. Moreno, M. Pérez-Elías, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.

J. J. de la Cruz, V. Soriano, M. Vogel, 2004, Clinical Infectious Diseases.

CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients: the role of intravenous drug use

J. Zamora, A. Muriel, C. Quereda, 2004, AIDS.

Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature.

R. Fernández-Muñoz, C. Quereda, S. Moreno, 2006, Human pathology.

Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy.

P. Martín-Dávila, E. Navas, E. Gómez-Mampaso, 2002, Archives of internal medicine.

HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b/ribavirin.

A. Muriel, P. Martín-Dávila, C. Quereda, 2005, Journal of hepatology.

Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.

C. Quereda, S. Moreno, M. Pérez-Elías, 2004, AIDS.

The contribution of telemedicine to hepatitis C elimination in a correctional facility.

J. Losa, C. F. Fernández Rodríguez, A. Delgado-Iribarren, 2019, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[Measurement of antimicrobial consumption using DDD per 100 bed-days versus DDD per 100 discharges after the implementation of an antimicrobial stewardship program].

J. Losa, L. Moreno, Roberto Collado, 2015, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Epidemiology and clinical features of tuberculosis in immigrants at an infectious diseases department in Madrid.

R. López-Vélez, E. Navas, E. Gómez-Mampaso, 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.